Related Experiment Video
Updated: Jun 20, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
Mutagenesis in vivo in T cells of p21-deficient mice
Changshun Shao1, Li Liang, Xin Zhao
1Department of Genetics, Rutgers University, Piscataway, NJ 08854, USA. shao@biology.rutgers.edu
Abstract:
Mice that are deficient in p53 exhibit an early onset of multiple types of tumors, especially thymic lymphoma. However, it remains unclear to what extent each of the p53-regulated pathways exerts its tumor suppressor activity. p21(Cip1/Waf1), acting down stream of p53, is a major G1/S checkpoint protein that restricts cell cycle progression into S phase in the presence of DNA damage. While at old ages p21-/- mice have a higher incidence of many types of tumors than p21+/+ mice, they are more resistant to thymic lymphomagenesis. In this study, we characterized mutagenesis in vivo in T cells of p21-deficient mice, using loss of heterozygosity (LOH) at Aprt locus as an indicator. We found that the spontaneous Aprt mutant frequency in T cells of p21-/- mice is lower than that in p21+/+ mice. The mutational spectra, however, are similar, with mitotic recombination being the predominant pathway. In contrast to the remarkable induction of LOH events in T cells of p53-/- mice exposed to X-rays, LOH in T cells of p21-/- mice is not significantly induced by X-rays. Correspondingly, lymphoid cells of p21-/- mice are more sensitive to IR-induced apoptosis than those of p21+/+ mice, in contrast to the radioresistance of p53-deficient lymphocytes. Reduction in mutation load in T cell lineages may contribute to the suppression of thymic lymphomagenesis in p21-/- mice.
Insights
Mice lacking p21, a protein that halts cell division after DNA damage, show fewer mutations in T cells and resistance to thymic lymphoma. This suggests p21
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- p53 tumor suppressor protein is crucial for preventing cancer.
- p21(Cip1/Waf1) is a downstream effector of p53, regulating the cell cycle.
- p21 deficiency increases tumor incidence but paradoxically reduces thymic lymphomagenesis.
Purpose of the Study:
- To investigate the role of p21 in mutagenesis within T cells.
- To understand the impact of p21 deficiency on DNA damage-induced mutations.
- To elucidate the mechanisms underlying p21's tumor suppressor activity in thymic lymphomagenesis.
Main Methods:
- Utilized p21-deficient (p21-/-) and wild-type (p21+/+) mice.
- Assessed mutagenesis in T cells using loss of heterozygosity (LOH) at the Aprt locus.
- Exposed mice to X-rays to study radiation-induced mutagenesis and apoptosis.
Main Results:
- Spontaneous Aprt mutant frequency was lower in p21-/- mice compared to p21+/+ mice.
- Mitotic recombination was the predominant mutational pathway in both genotypes.
- X-ray-induced LOH was not significantly increased in p21-/- mice, unlike in p53-/- mice.
- Lymphoid cells from p21-/- mice exhibited increased sensitivity to IR-induced apoptosis.
Conclusions:
- Reduced mutation load in T cell lineages may contribute to the observed resistance to thymic lymphomagenesis in p21-/- mice.
- p21 plays a significant role in suppressing mutagenesis and promoting apoptosis in response to DNA damage.
- These findings highlight distinct roles of p53 and p21 in tumor suppression and mutagenesis.
More Related Videos
Related Concept Videos
In-vitro Mutagenesis
In vitro Mutagenesis
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

